Navigation Links
Aida Granted Additional Anti-Cancer Patent
Date:10/11/2007

or potential replacement of surgery and radiation therapy for cancer. Potentially, over 8 million people can be treated each year in China with this drug.

About Aida Pharmaceuticals

Aida Pharmaceuticals is a product-focused pharmaceuticals company engaged in the formulation, clinical testing, registration, manufacture, sales and marketing of advanced pharmaceutical and genetic products in mainland China. The Company's mission is to discover, develop and market meaningful new therapies that improve human health. Aida Pharmaceuticals, in operation since March 1999, is headquartered in Hangzhou, China with manufacturing, distribution and sales points throughout mainland China. Aida is GMP certified in China and ISO9002 certified for quality assurance and ISO14000 certified for ecologically-friendly practices.


'/>"/>
SOURCE Aida Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Indian Doctor granted US patent on organ regeneration
2. Bail Granted To The Doctor Despite Her Patients Death
3. Azerbaijan Granted 5 million dollars in Fight Against Bird Flu
4. Developer Of Vaccine For Cancer Granted A Prestigious Fellowship
5. Lenalidomide, Granted Approval by FDA to Join Multiple Myeloma Drugs
6. American Senior Citizens Granted More Time
7. Numerous Defense Personnel Granted Early Retirement Due to Mental Illness
8. Man Accused of Spreading HIV Granted Bail in Australia
9. Additional Radiotheraphy for Breast Cancer
10. Adding An Additional Drug May Help Patients With Glaucoma
11. Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...HINGTON, July 25 /PRNewswire/ -- Klafter & Olsen L...Care Corporation ("ArthroCare" or the,"Company") (... U.S. District,Court for the Western District of T...hased the common stock ArthroCare from January 24,...chaser Class Period") and all,persons or entities ...
(Date:7/25/2008)...ASANTON, Calif., July 25 /PRNewswire-FirstCall/ --...der in device-based mechanical,circulatory support...arts,today announced that it will report its oper... months of fiscal 2008 on Thursday, July 31., The...s financial,results and operating activities to al...
(Date:7/25/2008)...ROOK, Ill. July 25, 2008 The American Society f...idelines on the role of endoscopy in the bariatric... in the United States and the success in surgical ...er of weight-loss surgeries performed in the U.S.,...lines discuss endoscopy in the preoperative patien...
(Date:7/25/2008)...ivanCotter Releases Results of Fourth Annual Physi...urvey, DETROIT, July 25 /PRNewswire/ -- Sullivan,...rth annual survey of physician on-call pay rates a...y Report. The survey report,with data from 132 he...ian,on-call pay practices and rates paid for 33 ph...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3
...in turmeric and onions has been found to help prev... Hopkins investigators.// The research was led by ...versity School of Medicine and Dr. Marcia Cruz-Cor... University of Puerto Rico School of Medicine. G...
...r. Edward A. Hirschowitz and Dr. Li Zhong could he...o are at high risk for developing the disease. // ...in United States and around the world mainly becau...e. The incidence of lung cancer in Kentucky is 49...
...g in public to avoid embarrassment. Stains caused...ng these stains will soon become more affordable w...e with stains avoided treatment as the treatment o...ike veneering, crowns and bonding were too costly ...
... in Laos led to the mass culling of more than 200 ...ing village in northeastern Thailand.// Thai off...land through contaminated eggs trays. But they als...elp needed to fight the disease effectively. Lives...
Other Medicine News:Health News:New Blood Test For Early Detection Of Lung Cancer 2Health News:Treating Tetracycline Stains Made More Affordable With New Treatment 2Health News:Treating Tetracycline Stains Made More Affordable With New Treatment 3
(Date:7/22/2008)...firms Tyrima Exhibits Excellent Drug-Like ...Support Initiation of Phase II Clinical Trials -, .../ -- CeNeRx BioPharma,Inc., a clinical stage comp...tments for diseases of the central nervous system,...te Tyrima(TM) into Phase II trials for the,treatme...
(Date:7/22/2008)... the Importance to Patients of Passing a ...HMOND, Va., July 22 /- Insm... biologics and biopharmaceuticals, today,announced...resent at a,Congressional briefing on Friday, July...tablishing an approval pathway for follow-on,biolo...
(Date:7/22/2008)...motherapy and pegylated enzyme produces signifi...alone - - Pegylated enzyme well t...all/ -- Halozyme Therapeutics,Inc. (Nasdaq: HALO...mercializing products targeting the extracellular ...ve pre-clinical animal efficacy data,for its pegyl...
(Date:7/22/2008)...ser Lipolysis Technology in the European ...ly 22 /- Cynosure, Inc.,(Na...r of a broad array of,light-based aesthetic treatm... Smartlipo MPX(TM), the company,s high-powered, du... and tighten skin through collagen,remodeling. The...
Breaking Medicine Technology:CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3ExonHit and bioMerieux Amend Their Strategic Partnership 2522 1ExonHit and bioMerieux Amend Their Strategic Partnership 2522 2ExonHit and bioMerieux Amend Their Strategic Partnership 2522 3Looking Older 3F How Square is Your Jaw Line 3F 1177 1Looking Older 3F How Square is Your Jaw Line 3F 1177 2Uses of medications in psychoanalysis 9315 1Uses of medications in psychoanalysis 9315 25 Factors Help Predict Psychosis in Children 9314 15 Factors Help Predict Psychosis in Children 9314 25 Factors Help Predict Psychosis in Children 9314 3
...LONA, SPAIN and SEATTLE, WA -- (MARKET WIRE) -- Ju...AQ: TGEN) today is,reporting data from the dose es...udy of tgAAC94 in patients with inflammatory,arthr... the,University of Washington School of Medicine, ...dish Medical Center, practicing,physician with Sea...
...APOLIS, June 13, 2007 /PRNewswire/ -- Two studies ...affect body sway at peak,plasma levels, nor did it...emory performance in patients who suffer from chro...ented at the 21st,Annual Meeting of the Associated...a are important because they show that ROZEREM may...
Other Medicine Technology:Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 2Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 4Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 5
... a potent naturally occurring androgen produced fr... 5a-reductase [1]. The concentrations of 5a-reduc...cluding genital skin and hair follicles, and are l...with the nuclear membrane. DHT exerts its biologi...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc.
UROSKOP Access, the dedicated urodiagnostic table with truly unrestricted patient access optimizes nearly all diagnostic and interventional procedures.
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential.
Medicine Products: